Loss from continuing operations before income taxes
(26,574
)
(26,818
)
(61,390
)
(47,880
)
(42,458
)
Income tax expense (benefit)
257
392
212
60
22
Net loss from continuing operations
(26,831
)
(27,210
)
(61,602
)
(47,940
)
(42,480
)
Loss from discontinued operations, net of tax(2)
—
(1,669
)
(11,918
)
(3,560
)
(2,494
)
Net loss
$
(26,831
)
$
(28,879
)
$
(73,520
)
$
(51,500
)
$
(44,974
)
Net loss per share basic and diluted:
Net loss from continuing operations per share
(0.46
)
(0.48
)
(1.08
)
(0.86
)
(0.78
)
Net loss from discontinued operations per share
—
(0.03
)
(0.21
)
(0.06
)
(0.05
)
Weighted-average number of shares used in calculating net loss per share
58,003,434
57,251,377
56,785,646
55,628,542
54,010,887
As of December 31,
(In thousands)
2017
2016
2015
2014
2013
Consolidated Balance Sheets Data:
Cash and cash equivalents
$
272,577
$
137,174
$
122,672
$
151,193
$
149,727
Short-term investments
$
167,479
$
161,396
$
—
$
—
$
—
Working capital
$
451,146
$
314,263
$
125,605
$
163,900
$
155,824
Long-term investments
$
125,549
$
—
$
—
$
—
$
—
Total assets
$
816,744
$
456,647
$
275,126
$
297,182
$
286,541
Current portion of long-term debt and capital lease obligations
$
—
$
269
$
5,519
$
3,380
$
2,637
Long-term debt and capital lease obligations(3)
$
566,173
$
332,768
$
171,967
$
166,283
$
117,627
Other long-term liabilities
$
6,030
$
5,032
$
3,952
$
2,774
$
1,943
Total stockholders’ equity
$
158,516
$
63,150
$
34,051
$
83,829
$
124,597
(1)
Includes a charge of $6.1 million related to in-process internally developed software in 2016.
(2)
Includes an impairment charge of $9.0 million in 2015 related to the impairment of the Neighborhood Diabetes asset group. See Note 19 to our consolidated financial statements included in this Annual Report on Form 10-K.
(3)
In June 2008, we issued and sold $85.0 million principal amount of 5.375% Convertible Senior Notes due June 2013. In June 2011, we issued and sold $143.8 million of 3.75% Convertible Notes due June 2016 and repurchased $70 million in principal of the 5.375% Notes. In June 2014, we issued and sold $201.3 million of 2% Convertible Notes due June 2019 and repurchased $114.9 million in 3.75% Notes. In July 2014, the remaining principal balance of the 3.75% Notes were converted and the principal was settled in cash. In September 2016, we issued $345.0 million of 1.25% Convertible Notes due September 2021 and repurchased $134.2 million in principal of the 2% Notes. In November 2017, we issued $402.5 million of 1.375% Convertible Notes due November 2024 and repurchased $63.4 million in principal of the 2% Notes. See Note 11 to our consolidated financial statements included in this Annual Report on Form 10-K.
filings.tools